Kv1.3 channel blocker (ImKTx88) maintains blood–brain barrier in experimental autoimmune encephalomyelitis

BACKGROUND: Disruption of blood–brain barrier (BBB) and subsequent infiltration of auto-reactive T lymphocytes are major characteristics of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). Kv1.3 channel blockers are demonstrated potential therapeutic effects on MS patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jie, Han, Song, Sun, Qi, Zhao, Yipeng, Liu, Junchen, Yuan, Xiaolu, Mao, Wenqian, Peng, Biwen, Liu, Wanhong, Yin, Jun, He, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463463/
https://www.ncbi.nlm.nih.gov/pubmed/28596825
http://dx.doi.org/10.1186/s13578-017-0158-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463463/
https://www.ncbi.nlm.nih.gov/pubmed/28596825
http://dx.doi.org/10.1186/s13578-017-0158-2

Ejemplares similares